Compositions and method for optimized peptide vaccines using residue optimization
AssigneeThink Therapeutics, Inc.
InventorsDavid Gifford, Brandon Carter
Life of this patent
Estimating the term…
Loading patent…
AssigneeThink Therapeutics, Inc.
InventorsDavid Gifford, Brandon Carter
Estimating the term…
Described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 19 to 50. Also described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 141 to 272. Also described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 273 to 322. Also described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 354 to 458.
An immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs:
Dependencies are inferred from the claim text.